Bio-Rad Laboratories Quick Ratio 2010-2023 | BIO
Historical quick ratio values for Bio-Rad Laboratories (BIO) over the last 10 years.
| Bio-Rad Laboratories Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2023-12-31 | $2.27B | $0.52B | 4.34 |
| 2023-09-30 | $2.37B | $0.56B | 4.25 |
| 2023-06-30 | $2.36B | $0.58B | 4.06 |
| 2023-03-31 | $2.52B | $0.59B | 4.28 |
| 2022-12-31 | $2.44B | $0.57B | 4.29 |
| 2022-09-30 | $2.45B | $0.57B | 4.30 |
| 2022-06-30 | $2.59B | $0.61B | 4.22 |
| 2022-03-31 | $2.70B | $0.65B | 4.16 |
| 2021-12-31 | $1.42B | $0.68B | 2.08 |
| 2021-09-30 | $1.88B | $0.65B | 2.89 |
| 2021-06-30 | $1.69B | $0.59B | 2.88 |
| 2021-03-31 | $1.57B | $0.61B | 2.57 |
| 2020-12-31 | $1.52B | $0.63B | 2.40 |
| 2020-09-30 | $1.68B | $0.99B | 1.71 |
| 2020-06-30 | $1.50B | $0.93B | 1.62 |
| 2020-03-31 | $1.53B | $0.87B | 1.76 |
| 2019-12-31 | $1.63B | $0.91B | 1.80 |
| 2019-09-30 | $1.46B | $0.43B | 3.36 |
| 2019-06-30 | $1.50B | $0.45B | 3.36 |
| 2019-03-31 | $1.44B | $0.44B | 3.24 |
| 2018-12-31 | $1.44B | $0.45B | 3.19 |
| 2018-09-30 | $1.43B | $0.45B | 3.16 |
| 2018-06-30 | $1.40B | $0.44B | 3.17 |
| 2018-03-31 | $1.37B | $0.46B | 2.99 |
| 2017-12-31 | $1.38B | $0.50B | 2.75 |
| 2017-09-30 | $1.29B | $0.47B | 2.77 |
| 2017-06-30 | $1.25B | $0.46B | 2.74 |
| 2017-03-31 | $1.17B | $0.41B | 2.88 |
| 2016-12-31 | $1.32B | $0.47B | 2.80 |
| 2016-09-30 | $1.29B | $0.44B | 2.92 |
| 2016-06-30 | $1.26B | $0.41B | 3.08 |
| 2016-03-31 | $1.24B | $0.40B | 3.10 |
| 2015-12-31 | $1.29B | $0.44B | 2.92 |
| 2015-09-30 | $1.28B | $0.44B | 2.95 |
| 2015-06-30 | $1.24B | $0.40B | 3.07 |
| 2015-03-31 | $1.22B | $0.42B | 2.94 |
| 2014-12-31 | $1.25B | $0.45B | 2.79 |
| 2014-09-30 | $1.25B | $0.50B | 2.48 |
| 2014-06-30 | $1.25B | $0.48B | 2.60 |
| 2014-03-31 | $1.25B | $0.48B | 2.60 |
| 2013-12-31 | $1.24B | $0.49B | 2.55 |
| 2013-09-30 | $1.15B | $0.46B | 2.49 |
| 2013-06-30 | $1.42B | $0.43B | 3.29 |
| 2013-03-31 | $1.40B | $0.45B | 3.13 |
| 2012-12-31 | $1.48B | $0.47B | 3.14 |
| 2012-09-30 | $1.39B | $0.43B | 3.20 |
| 2012-06-30 | $1.36B | $0.42B | 3.26 |
| 2012-03-31 | $1.35B | $0.44B | 3.05 |
| 2011-12-31 | $1.37B | $0.46B | 2.97 |
| 2011-09-30 | $1.43B | $0.42B | 3.45 |
| 2011-06-30 | $1.44B | $0.44B | 3.25 |
| 2011-03-31 | $1.37B | $0.43B | 3.20 |
| 2010-12-31 | $1.58B | $0.67B | 2.37 |
| 2010-09-30 | $1.25B | $0.41B | 3.04 |
| 2010-06-30 | $1.19B | $0.39B | 3.04 |
| 2010-03-31 | $1.16B | $0.40B | 2.92 |
| 2009-12-31 | $1.21B | $0.42B | 2.89 |
| 2009-09-30 | $1.12B | $0.42B | 2.69 |
| 2009-06-30 | $1.02B | $0.38B | 2.66 |
| 2009-03-31 | $0.68B | $0.36B | 1.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.989B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
| Stryker (SYK) | United States | $124.672B | 30.91 |
| Medtronic (MDT) | Ireland | $106.983B | 15.15 |
| Boston Scientific (BSX) | United States | $99.792B | 33.18 |
| EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
| ResMed (RMD) | United States | $26.527B | 26.52 |
| Terumo (TRUMY) | Japan | $25.252B | 35.66 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
| Baxter (BAX) | United States | $20.516B | 14.96 |
| Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
| Insulet (PODD) | United States | $11.513B | 60.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
| Demant (WILYY) | Denmark | $9.853B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
| Haemonetics (HAE) | United States | $4.247B | 21.72 |
| Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
| Envista Holdings (NVST) | United States | $3.456B | 13.14 |
| QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
| Neogen (NEOG) | United States | $2.552B | 24.54 |
| Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
| ICU Medical (ICUI) | United States | $2.348B | 17.52 |
| TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
| Owens & Minor (OMI) | United States | $1.856B | 17.82 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
| AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
| Warby Parker (WRBY) | United States | $1.218B | 0.00 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.964B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
| Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| Quanterix (QTRX) | United States | $0.623B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Jin Medical (ZJYL) | China | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
| PetIQ (PETQ) | United States | $0.486B | 18.14 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.422B | 25.82 |
| Biote (BTMD) | United States | $0.414B | 3.94 |
| OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
| Surmodics (SRDX) | United States | $0.361B | 39.06 |
| Zynex (ZYXI) | United States | $0.358B | 41.26 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Cerus (CERS) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
| Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.80 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.52 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |